Scarica l'app Stockscreener
24.55
1.52%
-0.38
Precedente Chiudi:
$24.93
Aprire:
$25
Volume 24 ore:
632.76K
Relative Volume:
0.61
Capitalizzazione di mercato:
$2.15B
Reddito:
$23.38M
Utile/perdita netta:
$-155.22M
Rapporto P/E:
-11.21
EPS:
-2.19
Flusso di cassa netto:
$-134.36M
1 W Prestazione:
-2.27%
1M Prestazione:
-1.17%
6M Prestazione:
+21.29%
1 anno Prestazione:
-37.32%
Intervallo 1D:
$24.04
$25.15
Intervallo di 1 settimana:
$24.04
$25.39
Portata 52W:
$13.45
$40.25
Ideaya Biosciences Inc Stock (IDYA) Company Profile
Nome
Ideaya Biosciences Inc
Settore
Industria
Telefono
650-443-6209
Indirizzo
5000 SHORELINE CT, SUITE 300, SOUTH SAN FRANCISCO, CA
Confronta IDYA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IDYA
Ideaya Biosciences Inc
|
24.55 | 2.18B | 23.38M | -155.22M | -134.36M | -2.19 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Ideaya Biosciences Inc Stock (IDYA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-22 | Iniziato | TD Cowen | Buy |
| 2025-07-10 | Ripresa | Goldman | Neutral |
| 2025-06-26 | Iniziato | Wells Fargo | Overweight |
| 2024-11-18 | Iniziato | Stephens | Overweight |
| 2024-11-05 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-10-24 | Iniziato | UBS | Buy |
| 2024-10-15 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-07-08 | Iniziato | Mizuho | Outperform |
| 2024-03-08 | Iniziato | BTIG Research | Buy |
| 2023-08-08 | Iniziato | SVB Securities | Outperform |
| 2023-05-24 | Iniziato | Goldman | Buy |
| 2023-04-24 | Aggiornamento | Stifel | Hold → Buy |
| 2023-03-23 | Iniziato | Berenberg | Buy |
| 2023-02-28 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-12-28 | Iniziato | CapitalOne | Overweight |
| 2022-10-27 | Iniziato | Citigroup | Buy |
| 2022-08-15 | Downgrade | Stifel | Buy → Hold |
| 2022-07-18 | Ripresa | Oppenheimer | Outperform |
| 2022-03-10 | Aggiornamento | Stifel | Hold → Buy |
| 2021-09-23 | Iniziato | Stifel | Hold |
| 2021-06-04 | Ripresa | Robert W. Baird | Outperform |
| 2021-03-11 | Iniziato | Guggenheim | Buy |
| 2020-10-07 | Iniziato | Wedbush | Outperform |
| 2020-09-01 | Iniziato | Northland Capital | Outperform |
| 2020-07-13 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2020-06-17 | Reiterato | H.C. Wainwright | Buy |
| 2020-04-06 | Iniziato | H.C. Wainwright | Buy |
| 2020-03-13 | Iniziato | ROTH Capital | Buy |
| 2019-10-17 | Iniziato | Oppenheimer | Outperform |
| 2019-09-10 | Iniziato | Robert W. Baird | Outperform |
| 2019-06-17 | Iniziato | Citigroup | Buy |
| 2019-06-17 | Iniziato | JP Morgan | Neutral |
| 2019-06-17 | Iniziato | Jefferies | Buy |
Mostra tutto
Ideaya Biosciences Inc Borsa (IDYA) Ultime notizie
Measuring IDEAYA Biosciences Inc.’s beta against major indices2025 Price Targets & Low Drawdown Investment Strategies - Newser
Real time scanner hits for IDEAYA Biosciences Inc. explainedTrade Exit Report & Weekly Stock Breakout Alerts - Newser
Analyzing IDEAYA Biosciences Inc. with risk reward ratio chartsJuly 2025 Rallies & Free Safe Entry Trade Signal Reports - Newser
Chart based analysis of IDEAYA Biosciences Inc. trendsEntry Point & AI Driven Stock Reports - Newser
Analyzing net buyer seller activity in IDEAYA Biosciences Inc.Portfolio Risk Summary & Technical Entry and Exit Alerts - Newser
Volatility clustering patterns for IDEAYA Biosciences Inc.Trade Volume Report & Risk Adjusted Swing Trade Ideas - Newser
IDEAYA Biosciences Inc. stock daily chart insightsExit Point & Reliable Price Breakout Alerts - Newser
What high frequency data says about IDEAYA Biosciences Inc.Weekly Stock Recap & Weekly Setup with ROI Potential - Newser
Is this a good reentry point in IDEAYA Biosciences Inc.Market Trend Report & Weekly Market Pulse Alerts - Newser
IDEAYA Biosciences Inc. stock retracement – recovery analysisWeekly Investment Recap & Stock Timing and Entry Methods - Newser
Regression analysis insights on IDEAYA Biosciences Inc. performanceVolume Spike & Daily Growth Stock Tips - Newser
Why IDEAYA Biosciences Inc. stock attracts strong analyst attentionEntry Point & Technical Pattern Alert System - Newser
Backtesting results for IDEAYA Biosciences Inc. trading strategiesTrade Risk Summary & Weekly High Potential Alerts - Newser
Risk adjusted return profile for IDEAYA Biosciences Inc. analyzedWeekly Trade Recap & Stepwise Entry and Exit Trade Signals - Newser
Can you recover from losses in IDEAYA Biosciences Inc.Weekly Trend Summary & Target Return Focused Picks - Newser
What data driven models say about IDEAYA Biosciences Inc.’s futureQuarterly Trade Summary & Daily Technical Stock Forecast Reports - Newser
Evaluating IDEAYA Biosciences Inc. with trendline analysisGlobal Markets & High Accuracy Buy Signal Tips - Newser
Is IDEAYA Biosciences Inc. gaining market share2025 Technical Patterns & Expert Approved Trade Ideas - sundaytimes.kr
IDEAYA Biosciences to Present First Median Overall Survival Data From Phase 2 Trial of the Darovasertib / Crizotinib Combination in Metastatic Uveal Melanoma at the 2025 Society for Melanoma Research Congress - 富途牛牛
Published on: 2025-08-30 04:01:01 - Newser
IDEAYA Biosciences Inc. Bounces Off Moving Average Support getLinesFromResByArray error: size == 0 - thegnnews.com
Is a relief rally coming for IDEAYA Biosciences Inc. holdersGap Down & AI Driven Stock Reports - Newser
How to escape a deep drawdown in IDEAYA Biosciences Inc.July 2025 Analyst Calls & Community Verified Swing Trade Signals - Newser
IDEAYA Grants Stock Options To Four New Hires Under Inducement Plan - Nasdaq
Relative strength of IDEAYA Biosciences Inc. in sector analysisOptions Play & Daily Profit Focused Stock Screening - Newser
Can IDEAYA Biosciences Inc. rally from current levelsJuly 2025 Drop Watch & AI Powered Market Entry Strategies - Newser
The Promise of Precision in Uveal Melanoma: IDEAYA Biosciences and the Race for First-in-Class Therapies - AInvest
IDEAYA Biosciences to Present First Median Overall Survival Data from Phase 2 Trial of the Darovasertib / Crizotinib Combination in Metastatic Uveal Melanoma at the 2025 Society for Melanoma Research Congress – Company AnnouncementFT.com - Financial Times
Published on: 2025-08-29 11:54:52 - Newser
Precision Biosciences shares rise 1.20% premarket after IDEAYA Biosciences announces inducement grants. - AInvest
Using Python tools to backtest IDEAYA Biosciences Inc. strategiesPortfolio Risk Summary & Expert Curated Trade Setup Alerts - Newser
IDEAYA Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - 富途牛牛
Ideaya Biosciences Inc Azioni (IDYA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.96%
1.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):